Literature DB >> 11136575

Ovarian function after surgical treatment for cervical cancer.

T E Buekers1, B Anderson, J I Sorosky, R E Buller.   

Abstract

OBJECTIVE: Our previous analysis found a high rate of early menopause in cervical cancer patients with ovarian transposition (OT) compared to a group that underwent radical hysterectomy (RH) alone. The current study evaluates ovarian function in the same group for a prolonged follow-up period and analyzes predictive factors for early menopause.
METHODS: One hundred two cervical cancer patients were treated with RH and/or lymphadenectomy and ovarian preservation from 1982 to 1989. A retrospective chart review was conducted, followed by a survey to determine the time of menopause.
RESULTS: Eighty-three patients underwent RH and 19 patients underwent a staging laparotomy. Eighty procedures included OT. Twenty-six patients received postoperative radiation therapy. The mean follow-up for premenopausal patients was 87.0 months. The average age of menopause for the 13 nonradiated patients without unilateral oophorectomy (UO) or OT was 50.6 years. After OT without radiation therapy, 98.0% of patients retained ovarian function for a mean of 126 months with menopause at a mean of 45.8 years. When OT and radiation therapy were added, 41% retained ovarian function for a mean of 43 months and a mean age at menopause of 36.6 years. A multivariate analysis of nonradiated patients correlated age at diagnosis and a combination of OT procedure and UO with earlier ovarian failure.
CONCLUSIONS: RH with bilateral ovarian preservation and without OT does not significantly reduce the age of menopause. The addition of UO or OT to this treatment reduces ovarian function appreciably. The addition of radiation therapy after OT dramatically shortens ovarian function. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11136575     DOI: 10.1006/gyno.2000.6039

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  The relationship between ovarian function and ovarian limited dose in radiotherapy postoperation of ovarian transposition in young patients with cervical cancer.

Authors:  Zhenhua Du; Hui Qu
Journal:  Cancer Med       Date:  2017-02-17       Impact factor: 4.452

2.  Ovarian survival after pelvic radiation: transposition until the age of 35 years.

Authors:  Ellen J Hoekman; Dan Knoester; Alexander A W Peters; Frank W Jansen; Cornelis D de Kroon; Carina G J M Hilders
Journal:  Arch Gynecol Obstet       Date:  2018-09-14       Impact factor: 2.344

3.  Does bilateral uterine artery ligation have negative effects on ovarian reserve markers and ovarian artery blood flow in women with postpartum hemorrhage?

Authors:  Fatma Ferda Verit; Orkun Çetin; Seda Keskin; Hürkan Akyol; Ali Galip Zebitay
Journal:  Clin Exp Reprod Med       Date:  2019-03-01

4.  Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint.

Authors:  Lina Yin; Saiquan Lu; Jun Zhu; Weiling Zhang; Guihao Ke
Journal:  Radiat Oncol       Date:  2019-06-10       Impact factor: 3.481

5.  Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy.

Authors:  Xiao-Juan Lv; Xiao-Long Cheng; Ye-Qiang Tu; Ding-Ding Yan; Qiu Tang
Journal:  Radiat Oncol       Date:  2019-12-16       Impact factor: 3.481

6.  Significance of ovarian transposition in the preservation of ovarian function for young cervical cancer patients undergoing postoperative volumetric modulated radiotherapy.

Authors:  Hanzi Xu; Chang Guo; Xiuming Zhang; Yaqin Wu; Biqing Zhu; Emei Lu; Zhihua Sun; Dan He; Fei Deng; Juan Lv; Zhen Gong
Journal:  Ann Transl Med       Date:  2021-12

7.  Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy.

Authors:  Wonguen Jung; Yun H Kim; Kyung S Kim
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

8.  Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis.

Authors:  Alexandros Laios; Mohamed Otify; Argyro Papadopoulou; Ioannis D Gallos; Thomas Ind
Journal:  BMC Womens Health       Date:  2022-07-22       Impact factor: 2.742

9.  Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility.

Authors:  Sami Al-Asari; Alaa Abduljabbar
Journal:  Ann Surg Innov Res       Date:  2012-09-17

Review 10.  Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis.

Authors:  Kumar Gubbala; Alex Laios; Ioannis Gallos; Pubudu Pathiraja; Krishnayan Haldar; Thomas Ind
Journal:  J Ovarian Res       Date:  2014-06-25       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.